title: Expression of 12/15-lipoxygenase attenuates intracellular lipid deposition during in vitro foam cell formation.
abstract: OBJECTIVE
  Lipoxygenases with different positional specificity have been implicated in atherogenesis, but the precise roles of the various isoforms remain unclear. Because of its capability of oxidizing low-density lipoprotein (LDL) to an atherogenic form, 12/15-lipoxygenases have been suggested to initiate LDL oxidation in vivo; thus, these enzymes may exhibit pro-atherogenic activities. However, in several rabbit atherosclerosis models, the enzyme appears to act atheroprotective.
  
  
  RESULTS
  To test the impact of 12/15-lipoxygenase expression on early atherogenesis, we established an in vitro foam cell model, which is based on the uptake of acetylated LDL by murine macrophages. In this system, we found that 12/15-lipoxygenase expression protects the cells from intracellular lipid deposition. This effect was related to an attenuated uptake of modified LDL, as indicated by impaired expression of scavenger receptor A and to accelerated intracellular lipid metabolism.
  
  
  CONCLUSIONS
  Our results indicate that the role of 12/15-lipoxygenase in atherogenesis may not be restricted to oxidative LDL modification. Expression of this lipid-peroxidizing enzyme may impact both lipid uptake and intracellular lipid turnover. These data provide a plausible explanation for the antiatherogenic effect of 12/15-LOX in rabbit atherosclerosis models.
authors.affiliation: Institute of Biochemistry, University Clinics Charité, Humboldt University, Berlin, Germany.
authors.forename: Jutta
authors.initials: J
authors.lastname: Belkner
authors.forename: Pavlos
authors.initials: P
authors.lastname: Chaitidis
authors.forename: Hannelore
authors.initials: H
authors.lastname: Stender
authors.forename: Christa
authors.initials: C
authors.lastname: Gerth
authors.forename: Ralf J
authors.initials: RJ
authors.lastname: Kuban
authors.forename: Tanihiro
authors.initials: T
authors.lastname: Yoshimoto
authors.forename: Hartmut
authors.initials: H
authors.lastname: Kuhn
mesh_terms: D000818:Animals; D001092:Arachidonate 12-Lipoxygenase / Q000235:genetics*; D001093:Arachidonate 15-Lipoxygenase / Q000235:genetics*; D018955:CD36 Antigens / Q000235:genetics; D002460:Cell Line; D008078:Cholesterol, LDL / Q000378:metabolism*; D015536:Down-Regulation; D005487:Foam Cells / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology*; D015971:Gene Expression Regulation, Enzymologic / Q000276:immunology*; D006801:Humans; D006868:Hydrolysis; D066298:In Vitro Techniques; D019787:Linoleic Acid / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000493:pharmacokinetics; D008247:Lysosomes / Q000201:enzymology; D051379:Mice; D019301:Oleic Acid / Q000378:metabolism; D011971:Receptors, Immunologic / Q000235:genetics; D051116:Receptors, Scavenger; D014162:Transfection
chemical_list: C475064:12-15-lipoxygenase; D018955:CD36 Antigens; D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; C032629:acetyl-LDL; D019301:Oleic Acid; D019787:Linoleic Acid; D001092:Arachidonate 12-Lipoxygenase; D001093:Arachidonate 15-Lipoxygenase